The Cosmetic Maintenance Economy: Surgery, Injectables, and Looking the Part
The Million Dollar Question: The most in-demand facelift surgeon in New York — the one credited with Kris Jenner’s viral 2025 result — reportedly charges roughly how much for a single facelift?
A) $30,000 B) $75,000 C) $150,000 D) $300,000Read on for the answer.
There’s a particular kind of face you start to notice once you know to look for it: rested, unlined, faintly luminous, ageless in a way that reads less as “young” than as “well-maintained.” It doesn’t look done. That’s the point. And the reason it doesn’t look done is that an enormous amount of quiet, recurring, expensive work went into making sure it wouldn’t. This piece is about that work — the injectables, the lasers, the surgery, and above all the calendar behind them. Not the one-time transformation people imagine, but the ongoing subscription that keeps the result from expiring.
What it is
The cosmetic maintenance economy is the machinery of looking the part, and the word that matters most in that phrase is maintenance. People tend to picture cosmetic work as a single dramatic event — a nose reshaped, a facelift, a before-and-after. In practice, at every wealth level, the modern version is a ladder of recurring upkeep, and almost nothing on it is permanent.
At the bottom of the ladder sits skincare and prescription topicals — retinoids, sunscreen, the unglamorous foundation everything else is built on. A rung up are the injectables: neuromodulators like Botox, Dysport, and their cousins, which relax the muscles that crease the skin, and dermal fillers, which restore or add volume. Above those are the energy devices — lasers, radiofrequency microneedling, ultrasound tightening — that resurface and firm without a scalpel. And at the top is actual surgery: eyelids, necks, and the facelift, the most involved and most expensive intervention of the set.
What unifies the ladder is expiration. Botox wears off in roughly three to four months. Most hyaluronic-acid fillers dissolve within six to eighteen months. Laser and device results fade as the skin keeps aging underneath them. Even a facelift — the closest thing to a durable fix — only resets the clock; it doesn’t stop it, and surgeons will tell you a good result buys somewhere around a decade before gravity resumes its work. So the honest way to describe the whole category is not “procedures people get” but “procedures people keep getting.” It is a form of consumption that looks like a purchase and behaves like a membership.
The scale is not niche. In its 2024 Plastic Surgery Statistics Report, the American Society of Plastic Surgeons counted more than 28 million minimally invasive procedures in a single year — over 91 percent of all cosmetic volume — with neuromodulators like Botox holding the top spot and rising another 4 percent year over year. The market for facial injectables alone was estimated at roughly $13 billion in 2025. This is not a fringe habit of the very rich. It is a mainstream consumer category — with a very rich tier layered on top of it.
Who uses it
The mistake is to imagine one customer. There are really three, sorted less by wealth than by age and intent, though money shapes how each behaves.
The youngest cohort is the prejuvenation crowd — people in their twenties and thirties who start early, deliberately, before the lines they’re treating have formed. The industry markets this as “baby Botox,” lower doses given to soften expression before wrinkles set. It has moved from novelty to norm astonishingly fast: NPR reported in late 2025 that preventative Botox in one’s twenties has become a mainstream skincare step, and ASPS data showed injectable-neurotoxin use grew more than 70 percent between 2019 and 2022 across age groups under 70. Affluence accelerates this — a young person with disposable income and a social circle that already normalizes it starts sooner and keeps a steadier schedule.
The middle cohort is the maintenance tier: people in their forties and fifties running a standing program of injectables plus periodic device treatments, managing the aging process rather than reversing it. This is the heart of the recurring economy — the reliable, quarterly, keep-it-up spender.
The top cohort is the surgical tier, generally fifties and older, where injectables and lasers can no longer do the structural work and the facelift enters the conversation. This is where the wealth gradient becomes dramatic. A mainstream patient and a very rich one might use the same Botox; they do not use the same facelift.
Two shifts are worth flagging. First, men — and specifically visible, working men — are a growing share. Executives, people who are on camera or in front of clients, increasingly treat maintenance as part of staying employable in a youth-tilted market. Second, the customer base has been swelled by an unexpected source: the wave of people on GLP-1 weight-loss drugs. Rapid weight loss deflates the face along with the body — the so-called “Ozempic face” — and a McKinsey 2025 survey found that 63 percent of GLP-1 patients seeking facial treatments had never used cosmetic medicine before. A weight-loss decision quietly became a cosmetic-maintenance decision for a large new group of people.
Why they use it
“Because they can afford it” explains the spending but not the motive, and the motives are more specific than vanity.
The first is economic. For anyone whose income depends on being seen — executives, founders, people in sales, media, entertainment, and law — appearance is not separate from the job. Looking tired, looking older than the room, looking like you’ve lost a step: at higher levels these read as signals, fairly or not, about energy and relevance. Maintenance is a hedge against that read. The camera made it worse. A decade of video calls turned everyone into a person who studies their own face on a screen for hours a day, and the aesthetics industry felt the effect directly.
The second is cultural, and it connects this topic to the broader optimization mindset. Among the wealthy, the same instinct that drives spending on longevity and healthspan — the desire to have the outside match a carefully managed inside — extends naturally to the face. If you are tracking your bloodwork, training with a coach, and sleeping on data, a sagging jawline starts to feel like an unoptimized variable. Cosmetic maintenance becomes the visible layer of a much larger wellness program.
The third is a shift in secrecy. For most of its history this was a hidden economy — you were not supposed to admit to it, and the highest compliment was that no one could tell. That norm is eroding at the top. When Kris Jenner’s strikingly refreshed appearance went viral in 2025, she eventually confirmed to the press that the work was done by New York surgeon Dr. Steven Levine rather than let the internet keep guessing. Younger celebrities like Hailey Bieber and Kylie Jenner have openly folded preventative Botox into their public beauty routines. The disclosure changes the demand: when the maintenance is admitted rather than concealed, the aspiration becomes purchasable, and more people go looking for the same providers.
How it works
The single most important thing to understand about the provider landscape is that it is two markets wearing similar clothing.
One is the injectable and device market, delivered largely through medical spas and aesthetic clinics, where the provider might be a physician but is often a nurse injector, physician assistant, or dermatology-adjacent practitioner. This is the high-volume, walk-in-and-out world: a Botox appointment takes fifteen minutes, most fillers are same-day with minimal downtime, and the entire relationship runs on a maintenance calendar. The clinic’s job, commercially, is to convert a one-time curious client into a standing quarterly one.
The other is the surgical market, delivered by board-certified plastic surgeons and facial plastic surgeons operating out of accredited surgical facilities. Here the front door is a consultation, often a paid one at the higher end, followed by a customized plan, real anesthesia, real recovery, and a result meant to last years. The flagship procedure is the facelift, and even within it there’s a hierarchy. A traditional SMAS facelift tightens the deeper connective layer beneath the skin; the more involved deep plane facelift releases and repositions that layer more completely, which is why it takes four to six hours, demands specialized training, and produces the “natural, not pulled” look the market now prizes — and why it costs more.
At the very top, the two markets converge into something closer to concierge care. The most sought-after surgeons run practices that function like private medical offices: long waits, high fees, tight discretion, and a clientele that expects total privacy. The surgeon credited with Kris Jenner’s result, Dr. Steven Levine, reportedly charges $5,000 for a consultation alone, and access itself becomes part of the product. You are not just buying a face. You are buying a wait list, a name, and the confidence that nobody will be able to tell.
What it costs
Costs sort cleanly by rung, and the spread from the mainstream to the top is enormous.
At the injectable level, a single Botox session typically runs $300 to $600, and because it fully wears off, patients repeat it three to four times a year. A syringe of dermal filler generally runs $500 to $1,500, touched up roughly annually. Add periodic laser or radiofrequency treatments and the annual total climbs quickly — practitioners describe $4,000 a year as a reasonable maintenance budget in one’s thirties and around $8,000 in one’s forties once several treatments are stacked. None of that touches surgery. It is simply the cost of standing still.
Surgery is a different order of magnitude, and here the wealth brackets matter:
- $1M–$5M. A deep plane facelift with a solid, credentialed surgeon commonly runs $18,000 to $40,000, all-in with facility and anesthesia fees. This is real money but within reach of the merely affluent as a once-a-decade expense.
- $5M–$30M. In markets like Manhattan and Beverly Hills, a top-reputation surgeon pushes the same procedure to $50,000 or beyond, often bundled with eyelid work, a neck lift, or fat grafting to restore lost volume — a combined facial rejuvenation that can reach the $30,000-to-$50,000-plus range.
- $30M–$100M+. At the summit sit a handful of surgeons whose names carry celebrity weight. Reporting on the field notes a few charging in excess of $150,000, and trade coverage of Dr. Levine put his facelift rate card around $300,000. At that level you are paying less for surgical minutes than for scarcity, discretion, and the specific look associated with one pair of hands.
The through-line: the injectable spend is a stream, and the surgical spend is a lump that resets the stream’s baseline. Neither ends. The lifetime figure is the one people never add up.
Hidden costs and tradeoffs
The most underappreciated cost isn’t a fee. It’s the treadmill itself. Because results expire, cosmetic maintenance is a commitment with no natural stopping point — pause the injectables and the face reverts, sometimes seeming to “catch up” in a way that feels abrupt. People who start in their twenties are, in effect, signing up for a fifty-year subscription, and the earlier they start the longer the tail.
Then there’s the failure mode of overdoing it. The industry has a name for the puffy, pillowed, subtly-wrong look that comes from years of accumulated filler — and correcting it is its own procedure, since fillers can be dissolved but the tissue changes and the habit are harder to undo. “More” is not the luxury version; at the top, the tell of unskilled or excessive work is precisely what money is spent to avoid.
Surgery adds the ordinary risks of surgery — anesthesia, scarring, nerve issues, imperfect symmetry, and the possibility of a result you don’t love and can’t quickly reverse — plus real downtime, which for busy, visible people is a scheduling cost as much as a physical one. Revisions happen, and they are neither cheap nor guaranteed.
There’s a psychological cost, too, and it’s the quietest one. A maintained face is a moving target: the standard you’re chasing keeps advancing, the mirror keeps offering new things to fix, and the same optimization instinct that makes the spending feel rational can make “enough” hard to locate. And the GLP-1 wave has added a downstream twist — the average GLP-1 patient loses roughly 11 percent of superficial facial volume, so a weight-loss win becomes a fresh maintenance obligation, and the American Academy of Facial Plastic and Reconstructive Surgery reported a 50 percent jump in fat-grafting procedures in 2024 as surgeons rushed to put volume back.
What people get wrong
The first misunderstanding is the one this whole piece is built around: that cosmetic work is one-and-done. It almost never is. The surgery is the visible event; the upkeep is the actual product, and anyone budgeting for the former without the latter is reading only half the bill.
The second is backwards intuition about “natural.” People assume a subtle, undetectable result is the cheap version and the dramatic one is the splurge. It’s the opposite. Natural results — the kind where no one can tell — require more skill, more restraint, and usually more money, because the hard part is doing exactly enough and not a hair more. The pulled, obvious look is what happens when the work is under-skilled, not under-funded.
The third is conflating injectors with surgeons. The med-spa nurse doing your Botox and the facial plastic surgeon doing a deep plane facelift occupy the same industry but not the same craft or risk tier, and a good outcome depends heavily on matching the provider to the procedure. The best-run affluent programs treat the two as separate specialties with a coordinating relationship — not interchangeable.
The fourth is the belief that more intervention equals a better result. Past a point, additional filler, additional tightening, and additional frequency make things worse, not better. The people who look the best are frequently the ones doing the least that works — which brings the whole subject back to its central irony.
Bottom line
So: D. The surgeon behind Kris Jenner’s viral result, Dr. Steven Levine, reportedly runs a facelift rate card around $300,000, with a $5,000 consultation just to get in the room — a figure that says less about surgical difficulty than about scarcity, discretion, and a name.
But the number to remember isn’t $300,000. It’s the one nobody advertises: the running total of a face maintained across decades — the quarterly Botox, the annual filler, the periodic lasers, the once-a-decade surgery that resets the baseline and starts the meter again. The wealthy don’t buy a younger face. They rent one, on a schedule, and the rent never stops. The genuine luxury purchase at the top of this market isn’t a more dramatic result — it’s the opposite: looking rested, unremarkable, and entirely like yourself, in a way that quietly conceals just how much upkeep “yourself” now requires.
Related reading: Longevity: How the Wealthy Spend on Healthspan · Wellness: Trainers, Retreats, and the Pursuit of Optimization · Concierge Medicine: Health Care for the Wealthy · Reputation: How the Wealthy Manage Image, Exposure, and Scandal · Wealth Levels: Life at $1M, $10M, $100M, and $1B
